PubMed=22086849; DOI=10.1158/0008-5472.CAN-11-1831; PMCID=PMC3286642
Judd N.P., Winkler A.E., Murillo-Sauca O., Brotman J.J., Law J.H., Lewis J.S. Jr., Dunn G.P., Bui J.D., Sunwoo J.B., Uppaluri R.
ERK1/2 regulation of CD44 modulates oral cancer aggressiveness.
Cancer Res. 72:365-374(2012)

PubMed=24668645; DOI=10.1158/1078-0432.CCR-14-0205; PMCID=PMC4096804
Onken M.D., Winkler A.E., Kanchi K.-L., Chalivendra V., Law J.H., Rickert C.G., Kallogjeri D., Judd N.P., Dunn G.P., Piccirillo J.F., Lewis J.S. Jr., Mardis E.R., Uppaluri R.
A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease.
Clin. Cancer Res. 20:2873-2884(2014)

PubMed=25729643; DOI=10.1016/j.gdata.2014.11.006; PMCID=PMC4340082
Chalivendra V., Kanchi K.-L., Onken M.D., Winkler A.E., Mardis E.R., Uppaluri R.
Genomic analysis to define molecular basis of aggressiveness in a mouse model of oral cancer.
Genom. Data 3:61-62(2015)